Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| 1 |
Pinduoduo
PDD
|
$985M |
| 2 |
RTX Corp
RTX
|
$517M |
| 3 |
Bank of America
BAC
|
$445M |
| 4 |
Comcast
CMCSA
|
$428M |
| 5 |
Cisco
CSCO
|
$363M |
Top Sells
| 1 |
Alibaba
BABA
|
$1.03B |
| 2 |
Thermo Fisher Scientific
TMO
|
$458M |
| 3 |
JD.com
JD
|
$385M |
| 4 |
PPL Corp
PPL
|
$376M |
| 5 |
AMC Entertainment Holdings
AMC
|
$342M |
Sector Composition
| 1 | Technology | 19.34% |
| 2 | Consumer Discretionary | 13.34% |
| 3 | Financials | 12.95% |
| 4 | Healthcare | 11.95% |
| 5 | Industrials | 9.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3726
Future FinTech Group
FTFT
$7.73M
| $133K | ﹤0.01% |
842
-179
| -18% | -$28.3K |
|
|
SURF
3727
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $131K | ﹤0.01% |
+17,587
| New | +$131K |
|
3728
Neurogene
NGNE
$285M
| $130K | ﹤0.01% |
+704
| New | +$130K |
|
3729
The ONE Group
STKS
$85.1M
| $128K | ﹤0.01% |
+11,611
| New | +$128K |
|
3730
DURECT Corp
DRRX
$59.3M
| $127K | ﹤0.01% |
7,788
-4,415
| -36% | -$72K |
|
3731
NiSun International Enterprise Development Group
NISN
$17.3M
| $127K | ﹤0.01% |
1,184
-327
| -22% | -$35.1K |
|
3732
Lineage Cell Therapeutics
LCTX
$279M
| $126K | ﹤0.01% |
+44,447
| New | +$126K |
|
|
AKTS
3733
DELISTED
AKOUSTIS TECHNOLOGIES, INC.
AKTS
| $125K | ﹤0.01% |
+11,643
| New | +$125K |
|
|
NAGE
3734
Niagen Bioscience, Inc. Common Stock
NAGE
$750M
| $124K | ﹤0.01% |
12,553
-799,151
| -98% | -$7.89M |
|
|
RTLR
3735
DELISTED
Rattler Midstream LP Common Units
RTLR
| $123K | ﹤0.01% |
11,283
-2,202
| -16% | -$24K |
|
3736
PAVmed
PAVM
$9.77M
| $123K | ﹤0.01% |
1,284
-1,144
| -47% | -$110K |
|
|
XNET
3737
Xunlei
XNET
$479M
| $123K | ﹤0.01% |
27,027
-7,293
| -21% | -$33.2K |
|
3738
Korea Electric Power
KEP
$17.2B
| $122K | ﹤0.01% |
+11,299
| New | +$122K |
|
3739
Cartesian Therapeutics
RNAC
$277M
| $122K | ﹤0.01% |
971
+84
| +9% | +$10.6K |
|
|
SIEN
3740
DELISTED
Sientra, Inc.
SIEN
| $122K | ﹤0.01% |
+1,534
| New | +$122K |
|
3741
Korro Bio
KRRO
$312M
| $121K | ﹤0.01% |
+244
| New | +$121K |
|
3742
Tiptree Inc
TIPT
$849M
| $121K | ﹤0.01% |
+13,018
| New | +$121K |
|
3743
Summit Therapeutics
SMMT
$19.3B
| $120K | ﹤0.01% |
+16,139
| New | +$120K |
|
3744
Puma Biotechnology
PBYI
$253M
| $118K | ﹤0.01% |
12,825
+1,980
| +18% | +$18.2K |
|
3745
Apyx Medical
APYX
$74.1M
| $117K | ﹤0.01% |
+11,401
| New | +$117K |
|
|
LUNA
3746
DELISTED
Luna Innovations Incorporated
LUNA
| $117K | ﹤0.01% |
10,865
-149
| -1% | -$1.61K |
|
3747
NexGen Energy
NXE
$4.46B
| $116K | ﹤0.01% |
+28,199
| New | +$116K |
|
3748
CEL-SCI Corp
CVM
$72.2M
| $114K | ﹤0.01% |
440
+26
| +6% | +$6.74K |
|
|
EXK
3749
Endeavour Silver
EXK
$1.74B
| $113K | ﹤0.01% |
+18,411
| New | +$113K |
|
|
URG
3750
Ur-Energy
URG
$536M
| $111K | ﹤0.01% |
+79,166
| New | +$111K |
|